GTHX logo

G1 Therapeutics (GTHX) Operating Profit

Annual Operating Profit

-$39.53 M
+$96.65 M+70.97%

December 31, 2023

Summary

Performance

1-Year Change

+70.97%

3-Year Change

+59.03%

5-Year Change

+55.73%

15-Year Change

+35.17%

GTHX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$15.42 M

3-Year Low

-$142.46 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GTHX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
GTHX next annual earnings announcement has not yet been scheduled

OtherGTHXprofitabilitymetrics:

Annual Operating Margin

-47.91%
GTHX annual operating profit margin is -47.91%

Annual Revenue

$82.51 M
GTHX annual revenue is $82.51 million

Annual Net Income

-$47.97 M
GTHX annual net profit is -$47.97 million

Annual EPS

-$0.93
GTHX annual earnings per share is -$0.93

Quarterly Operating Profit

-$3.54 M
+$5.51 M+60.93%

June 30, 2024

Summary

Performance

3-Month Change

+60.93%

1-Year Change

-130.7%

3-Year Change

-130.7%

5-Year Change

+89.15%

GTHX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.52 M
GTHX quarterly operating income is currently -130.70% below its historical high of $11.52 million

3-Year Low

-$46.78 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
GTHX previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
GTHX next earnings announcement has not yet been scheduled

OtherGTHXprofitabilitymetrics:

Quarterly Operating Margin

-21.36%
GTHX quarterly operating profit margin is -21.36%

Quarterly Revenue

$16.55 M
GTHX quarterly revenue is $16.55 million

Quarterly Net Income

-$5.47 M
GTHX quarterly net profit is -$5.47 million

Quarterly EPS

-$0.10
GTHX quarterly earnings per share is -$0.10

TTM Operating Profit

-$37.88 M
-$15.05 M-65.93%

June 30, 2024

Summary

Performance

3-Month Change

-65.93%

1-Year Change

+43.18%

3-Year Change

+43.18%

5-Year Change

+71.57%

GTHX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$5.95 M

3-Year Low

-$163.70 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
GTHX previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
GTHX next earnings announcement has not yet been scheduled

OtherGTHXprofitabilitymetrics:

Annual Operating Margin

-47.91%
GTHX annual operating profit margin is -47.91%

TTM Revenue

$58.20 M
GTHX TTM revenue is $58.20 million

TTM Net Income

-$44.77 M
GTHX TTM net profit is -$44.77 million

TTM EPS

-$0.86
GTHX TTM earnings per share is -$0.86

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$39.53 M
GTHX annual operating income is -$39.53 million

Annual Gross Profit

$75.32 M
GTHX annual gross profit is $75.32 million

Annual Operating Expenses

$114.84 M
GTHX annual total operating expenses is $114.84 million

GTHX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.0%-130.7%+43.2%
3 y3 years+59.0%-130.7%+43.2%
5 y5 years+55.7%+89.2%+71.6%

GTHX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+260.4%-130.7%+1223.4%+65.9%+332.2%
5 y5-yearat high+260.4%-130.7%+1223.4%+65.9%+332.2%
alltimeall time+156.3%+260.4%-130.7%+1223.4%+537.0%+332.2%

G1 Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Jun 2024
-
-$3.54 M(-60.9%)
-$37.88 M(+65.9%)
Mar 2024
-
-$9.05 M(+1.3%)
-$22.83 M(-42.2%)
Dec 2023
-$39.53 M(-71.0%)
-$8.93 M(-45.4%)
-$39.53 M(-35.7%)
Sep 2023
-
-$16.37 M(-242.1%)
-$61.48 M(-7.8%)
Jun 2023
-
$11.52 M(-144.7%)
-$66.67 M(-42.1%)
Mar 2023
-
-$25.75 M(-16.6%)
-$115.14 M(-15.4%)
Dec 2022
-$136.18 M(-4.4%)
-$30.89 M(+43.3%)
-$136.18 M(-4.7%)
Sep 2022
-
-$21.55 M(-41.7%)
-$142.88 M(-12.1%)
Jun 2022
-
-$36.96 M(-21.0%)
-$162.47 M(-0.8%)
Mar 2022
-
-$46.78 M(+24.5%)
-$163.70 M(+14.9%)
Dec 2021
-$142.46 M(+47.7%)
-$37.59 M(-8.6%)
-$142.46 M(+10.5%)
Sep 2021
-
-$41.14 M(+7.7%)
-$128.96 M(+32.2%)
Jun 2021
-
-$38.19 M(+49.6%)
-$97.56 M(+8.2%)
Mar 2021
-
-$25.54 M(+6.0%)
-$90.19 M(-6.5%)
Dec 2020
-$96.48 M
-$24.09 M(+147.2%)
-$96.48 M(-11.4%)
Sep 2020
-
-$9.74 M(-68.4%)
-$108.94 M(-18.2%)
Jun 2020
-
-$30.82 M(-3.1%)
-$133.22 M(-1.3%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$31.82 M(-12.9%)
-$134.98 M(+4.6%)
Dec 2019
-$129.04 M(+44.5%)
-$36.55 M(+7.4%)
-$129.04 M(+8.8%)
Sep 2019
-
-$34.02 M(+4.4%)
-$118.57 M(+12.5%)
Jun 2019
-
-$32.58 M(+25.9%)
-$105.37 M(+11.6%)
Mar 2019
-
-$25.88 M(-0.8%)
-$94.44 M(+5.8%)
Dec 2018
-$89.29 M(+46.4%)
-$26.09 M(+25.3%)
-$89.29 M(+10.9%)
Sep 2018
-
-$20.82 M(-3.8%)
-$80.48 M(+6.5%)
Jun 2018
-
-$21.65 M(+4.5%)
-$75.59 M(+9.1%)
Mar 2018
-
-$20.73 M(+19.9%)
-$69.31 M(+13.7%)
Dec 2017
-$60.97 M(+100.6%)
-$17.28 M(+8.5%)
-$60.97 M(+12.7%)
Sep 2017
-
-$15.93 M(+3.6%)
-$54.09 M(+20.8%)
Jun 2017
-
-$15.38 M(+24.2%)
-$44.77 M(+21.6%)
Mar 2017
-
-$12.38 M(+19.0%)
-$36.82 M(+21.2%)
Dec 2016
-$30.39 M(+97.0%)
-$10.40 M(+57.3%)
-$30.39 M(+52.0%)
Sep 2016
-
-$6.61 M(-11.0%)
-$19.99 M(+49.4%)
Jun 2016
-
-$7.43 M(+24.9%)
-$13.38 M(+124.9%)
Mar 2016
-
-$5.95 M
-$5.95 M
Dec 2015
-$15.42 M
-
-

FAQ

  • What is G1 Therapeutics annual operating income?
  • What is the all time high annual operating profit for G1 Therapeutics?
  • What is G1 Therapeutics annual operating profit year-on-year change?
  • What is G1 Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for G1 Therapeutics?
  • What is G1 Therapeutics quarterly operating profit year-on-year change?
  • What is G1 Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for G1 Therapeutics?
  • What is G1 Therapeutics TTM operating profit year-on-year change?

What is G1 Therapeutics annual operating income?

The current annual operating profit of GTHX is -$39.53 M

What is the all time high annual operating profit for G1 Therapeutics?

G1 Therapeutics all-time high annual operating income is -$15.42 M

What is G1 Therapeutics annual operating profit year-on-year change?

Over the past year, GTHX annual operating income has changed by +$96.65 M (+70.97%)

What is G1 Therapeutics quarterly operating income?

The current quarterly operating profit of GTHX is -$3.54 M

What is the all time high quarterly operating profit for G1 Therapeutics?

G1 Therapeutics all-time high quarterly operating income is $11.52 M

What is G1 Therapeutics quarterly operating profit year-on-year change?

Over the past year, GTHX quarterly operating income has changed by -$15.05 M (-130.70%)

What is G1 Therapeutics TTM operating income?

The current TTM operating profit of GTHX is -$37.88 M

What is the all time high TTM operating profit for G1 Therapeutics?

G1 Therapeutics all-time high TTM operating income is -$5.95 M

What is G1 Therapeutics TTM operating profit year-on-year change?

Over the past year, GTHX TTM operating income has changed by +$28.79 M (+43.18%)